What pharmacotherapeutics should one use for early stage non-small cell lung cancer?

Expert Opin Pharmacother. 2018 Sep;19(13):1403-1406. doi: 10.1080/14656566.2018.1510915. Epub 2018 Aug 16.

Authors

Ciro Battiloro¹, Luigi Della Gravara², Danilo Rocco¹, Cesare Gridelli³

Affiliations

¹ a UOC Pneumologia Oncologica , AORN Azienda Ospedaliera Dei Colli Monaldi , Napoli , Italy.
² b Università Degli Studi Della Campania Luigi Vanvitelli , Caserta , Italy.
³ c Hematology and Oncology Department , AORN Giuseppe Moscati , Avellino , Italy.

PMID: 30113230
DOI: 10.1080/14656566.2018.1510915

No abstract available

Keywords: Early stage; adjuvant therapy; chemotherapy; immunotherapy; non small cells lung cancer; targeted therapy.

Publication types

Editorial